Metronidazole susceptibility and the presence of hydrogenase in pathogenic bacteria

Anaerobe

Volumn 2, Issue 3, 1996, Pages 147-153

  Church, Deirdre L ^a,b,c   Bryant, Richard D ^a   Valerie, Sim ^d   Laishley, Edward J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c ALBERTA CHILDREN'S HOSPITAL   (Canada)

^d NONE

Author keywords

Bacteria; Hydrogenase; Metronidazole; Susceptible

Indexed keywords

HYDROGENASE; METRONIDAZOLE;

ANAEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEROIDES FRAGILIS; EGGERTHELLA LENTA; FUSOBACTERIUM NECROPHORUM; FUSOBACTERIUM NUCLEATUM; HELICOBACTER PYLORI; LACTOBACILLUS; NONHUMAN; PATHOGENICITY; PEPTOSTREPTOCOCCUS; PRIORITY JOURNAL; PROPIONIBACTERIUM; VEILLONELLA;

BACTERIA (MICROORGANISMS); BACTEROIDES FRAGILIS; CLOSTRIDIA; EGGERTHELLA LENTA; FINEGOLDIA MAGNA; FUSOBACTERIUM NECROPHORUM; FUSOBACTERIUM NUCLEATUM; HELICOBACTER PYLORI; LACTOBACILLUS; PEPTOSTREPTOCOCCUS; PROPIONIBACTERIUM; VEILLONELLA; VEILLONELLA PARVULA;

EID: 0030176204     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1006/anae.1996.0019     Document Type: Article

References (32)

1. 1. Finegold S.M. (1980) Metronidazole. Ann Int Med 93: 585-587
2. 2. Tally E.P., Goldin B.R., Sullivan N., Johnston J. and Gorbach S.L. (1979) Antimicrobial activity of metronidazole in anaerobic bacteria. Antimicrob Agents Chemother 13: 460-465
3. 3. Mathiesen G.E. and Finegold S.M. (1994) Metronidazole and other nitroimidazoles. In Gorbach S.L., Barlett J.G. and Blacklow N.R. (eds) Infectious Diseases, pp 260-265. W.B. Saunders Company, Philadelphia
4. 4. Metronidazole. (1990) Kucers A. and Bennett N.McK. (eds) The Use of Antibiotics (A Comprehensive Review with Clinical Emphasis). 4th Edn, pp 1290-1329, J.B. Lippincott Company, Philadelphia
5. 5. Finegold S.M., George W.L. and Mulligan M.E. (1986) Anaerobic Infections (A Disease-a Month Classic). Year Book Medical Publishers, Inc., Chicago
6. 6. Finegold S.M. and George W.L. (eds) (1989). Anaerobic Infections in Humans. Academic Press Inc., San Diego
7. 7. Jokipii A.M.M., Myllyla V.V., Hokkanen E. and Jokipii L. (1977) Penetration of the blood brain barrier by metronidazole and tinidazole. J Antimicrob Chemother 3: 239-245
8. 8. McNulty C.A. (1987) The treatment of Campylobacter-associated gastritis. Am J Gastrenterol 82: 245-247
9. 9. Rauws E.A.J., Langenberg W., Houthoff H.J., Zanen H.C. and Tytgat G.N.J. (1988) Campylobacter pylori-associated chronic antral gastritis: a prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94: 33-40
10. 10. Rauws E.A.J. and Tytgat G.N.J. (1990) Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 335: 1233-1235
11. 11. Lockerby D.L., Rabin H.R., Bryan L.E. and Laishley E.J. (1984) Ferredoxin-linked reduction of metronidazole in Clostridium pasteurianum. Antimicrob Agents Chemother 26: 665-669
12. 12. Church D.L., Rabin H.R. and Laishley E.J. (1985) Role of the phosphoroclastic reaction of Clostridium pasteurianum in the reduction of metronidazole. Antimicrob Agents Chemother 27: 863-867
13. 13. Church D.L., Rabin H.R. and Laishley E.J. (1988) Role of hydrogenase 1 of Clostridium pasteurianum in the reduction of metronidazole. Biochem Pharmacol 37: 1525-1534
14. 14. Church D.L. and Laishley E.J. (1995) Reduction of metronidazole by hydrogenase from Clostridia. Anaerobe 1: 81-92
15. 15. Ingham H.R., Eaton A., Venables C.W. and Adams P.C. (1978) Bacteroides fragilis resistant to metronidazole after long term therapy (letter). Lancet 1:214
16. 16. Costerton J.W., Boivin J.W., Laishley E.J. and Bryant R.D. (1989) A new test for microbial corrosion. Proceedings of the 6th Asian-Pacific Corrosion Control Conference, pp 20-25
17. 17. Bryant R.D., Jansen W., Boivin J.W., Laishley E.J. and Costerton J.W. (1991) The effect of hydrogenase and mixed sulfate reducing bacteria (SRB) populations on the corrosion of steel. Applied and Environmental Microbiol 57: 2804-2809
18. 18. Laishley E.J. and Krouse H.R. (1971) A ferredoxin-linked sulfite reductase from Clostrium pasteurianum. Can J Microbiol 17: 889-895
19. 19. National Consensus Committee for Laboratory Standards (NCCLS). 1(1993) Methods for antimicrobial susceptibility testing of anaerobic bacteria-Third Edn. Approved Standard M11-A3, 13 (26): 1-15
20. 20. National Consensus Committee for Laboratory Standards (NCCLS). (1993) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-3rd Edn. Approved Standard M11-A2, 13 (25): 1-25
21. 21. Adams M.W.W., Mortenson L.E. and Chen J.S. (1981) Hydrogenase. Biochim Biophys Acta 594: 105-176
22. 22. Santangelo J.D., Jones D.T. and Woods D.R. (1991) Metronidazole activation and isolation of Clostridium acetobutylicum electron transport genes. J Bacteriol 173: 1088-1095
23. 23. Narikawa S. (1986) Distribution of metronidazole susceptibility factors in obligate anaerobes. J Antimicrob Chemother 18: 565-574
24. 24. Marczak R., Gorell T.E. and Muller M. (1983) Hydrogenosomal ferredoxin of the anaerobic protozoan, Tritrichomonas foetus. J Biol Chem 258: 12427-12433
25. 25. Lindmark D.G. and Muller M. (1973) Hydrogenosome, a cytoplasmic organelle of the anaerobic flagellate Tritrichomonas foetus, and its role in pyruvate metabolism. J Biol Chem 248: 7724-7728
26. 26. Yartlett N., Gorell T.E., Marczak R. and Muller M. (1985) Reduction of nitroimidazole derivatives by hydrogenosomal extracts of Trichomonas vaginalis. Mol Biochem Parasitol 14: 29-40
27. 27. Townson S.M., Hanson G.R., Upcroft J.A. and Upcroft P. (1994) A purified ferredoxin from Giardia duodenalis. Eur J Biochem 220: 439-446
28. 28. Tally F.P, Goldin B. and Sullivan N.E. (1981) Nitroimidazoles: In vitro activity and efficacy in anaerobic infections. Scand J Infect Dis Suppl 26: 46-53
29. 29. Malfertheiner P. (1993) Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scand J Gastroenterol 28 Suppl 196: 34-37
30. 30. Lacy S.L., Moss S.F. and Taylor G.W. (1993) Metronidazole uptake by sensitive and resistant isolates of Helicobacter pylori. J Antimicrob Chemother 32: 393-400
31. 31. Adams M.W.W. and Hall D.O. (1979) Purification of the membrane-bound hydrogenase of Escherichia coli. Biochem J 183: 11-22
32. 2 metabolism in Escherichia coli. J Bacterial 162: 353-360